Merck (MRK) has received approval from the European Commission for a subcutaneous injectable version of Keytruda ...
Merck is buying Cidara Therapeutics for $9.2B, picking up an experimental flu therapy as it looks to broaden its pipeline.
Merck will acquire Cidara Therapeutics in a nearly $9.2 billion deal, gaining access to an experimental flu drug in its ...
Merck & Co. has struck a $9.2 billion deal to buy biotechnology company Cidara Therapeutics in a move that bolsters the ...
The Promega OncoMate® MSI Dx Analysis System has received FDA approval as a companion diagnostic for KEYTRUDA® plus LENVIMA® ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback